|Year : 2013 | Volume
| Issue : 12 | Page : 689-698
Intestinal amebiasis: A concerning cause of acute gastroenteritis among hospitalized Lebanese children
Amal Naous, Ziad Naja, Nour Zaatari, Raymond Kamel, Mariam Rajab
Department of Pediatrics, Makassed General Hospital, Beirut, Lebanon
|Date of Web Publication||18-Dec-2013|
Department of Pediatrics, Makassed General Hospital, BeirutDepartment of Pediatrics, Makassed General Hospital, Beirut
Source of Support: None, Conflict of Interest: None
Background: Intestinal amebiasis is an important public health problem worldwide. More severe disease is associated with young age, malnutrition and immunosuppression. Aim: The aim of this study is to evaluate the prevalence and characteristic nature of intestinal amebiasis among pediatric population, and compare it with other causes of gastroenteritis. Materials and Methods: This is a retrospective comparative study conducted at Makassed General Hospital between January 2008 and December 2012, including all pediatric patients between birth and 15 years of age, who presented with symptoms of acute gastroenteritis. Results: One thousand three hundred ninety-five patients were included in the study, and were divided into four groups: Group I (Entameba histolytica group = 311 cases, 22.3%), group II (Rotavirus group = 427 cases, 30.6%), group III (bacterial group = 107 cases, 7.7%), group IV (unidentified group = 550 cases, 39.4%). Significant leukocytosis, neutrophilia and positive C-reactive protein were found among more than 50% of admitted Entemaba histolytica cases with a picture of severe invasive disease in young infants. Conclusion: Entameba histolytica can be an emerging serious infection, especially when it finds suitable environmental conditions and host factors, so we should be ready to face it with effective preventive measures.
Keywords: Intestinal amebiasis, Entameba histolytica; E. histolytica, Gastroenteritis
|How to cite this article:|
Naous A, Naja Z, Zaatari N, Kamel R, Rajab M. Intestinal amebiasis: A concerning cause of acute gastroenteritis among hospitalized Lebanese children. North Am J Med Sci 2013;5:689-98
|How to cite this URL:|
Naous A, Naja Z, Zaatari N, Kamel R, Rajab M. Intestinal amebiasis: A concerning cause of acute gastroenteritis among hospitalized Lebanese children. North Am J Med Sci [serial online] 2013 [cited 2022 May 18];5:689-98. Available from: https://www.najms.org/text.asp?2013/5/12/689/123253
| Introduction|| |
Amebiasis caused by the intestinal parasite Entameba histolytica, is a disease of global health importance, especially in developing countries. , It has an estimated worldwide prevalence of 50 million cases of symptomatic disease and is responsible for 40000-110000 deaths annually. It is the third leading parasitic cause of death worldwide. ,, Amebiasis is defined as an intestinal or extraintestinal disease due to the parasite E. histolytica.,,] E. histolytica is transmitted via the fecal-oral route. The infection causes a variety of clinical presentations, from asymptomatic colonization to invasive amebic dysentery and extra-intestinal amebiasis. 
E. histolytica has a two-stage life cycle, existing as resistant infective cysts in the environment and potentially pathogenic trophozoites in the human colon. The more common path is commensal colonization, where trophozoites inhabit the gut lumen and feed on enteric bacteria by phagocytosis. , The less common path leads to invasive amebiasis. Virulence factors allow the parasite to cause pathogenic amebiasis. The cysts transform to trophozoites which degrade the colonic mucosal layer and bind to host epithelial cells. The trophozoites trigger pathology in the host tissues, promoting penetration and infection. ,,,
The rate of infection by E. histolytica differs among countries, socio-economic and sanitary conditions, and populations. It is highly endemic throughout poor and socio-economically deprived communities in the tropics and subtropics. ,, In developing countries, parasitic diseases represent a social and economic problem with more severe disease associated with young age, malnutrition, and immunosuppression. , In industrialized nations, on the other hand, populations at greatest risk for severe intestinal protozoan infections include immunocompromised patients. 
Previous study done in Lebanon showed that E. histolytica is more prevalent in adults than in children.  In view of lack of information concerning intestinal amebiasis and its impact among Lebanese children, we decided to conduct this study to assess the prevalence, characteristic nature and risk factors for intestinal amebiasis necessitating hospitalization in infants and children, and in comparison with other hospitalized children with non E. histolytica gastroenteritis (GE).
| Materials and Methods|| |
This is a retrospective comparative study that was carried out at Makassed General Hospital, Beirut, Lebanon, which is a tertiary referral medical center. Infants and children between birth and 15 years of age with acute GE, who necessitated hospitalization or Emergency Department (ED) management, were enrolled in the study, during the period from January 2008 through December 2012. This study was approved by the research and ethical committee of the hospital institutional review board. For better comparative analysis and characterization of E. histolytica cases, a cross-sectional comparative study was conducted as all acute GE cases were divided into four main groups: Group I (confirmed E. histolytica cases), group II (confirmed Rotavirus (RV) cases), and group III (confirmed bacterial gastroenteritis), group IV (GE with unidentified enteropathogens).
Patients more than 15 years, patients with chronic diarrhea, patients with immunodeficiency, or having any extraintestinal infection at the time of hospitalization were excluded from the study. Patients with diarrheal illness who had received antibiotics in the preceding 1 month that might be related to Clostridium difficile-associated diarrhea or antibiotic-associated pseudomembranous colitis, and patients who had combined gastrointestinal infection with more than one organism were also excluded from the study.
Medical records of all patients, from birth to 15 years of age with acute GE, who necessitated Emergency Department management or hospitalization, during the period from January 2008 through December 2012 were subjected to thorough review and analysis.
The following data on admission for all patients in pediatric ED: Age, gender, residency, season and year of admission, duration of stay, complete history and physical examination were recorded. However, data about type of nutrition were not documented in the ED medical charts, and laboratory investigations with stool sampling were not routinely done for every case of acute GE presenting to ED.
On the other hand, complete data were recorded in the medical charts of hospitalized patients.All infants and children hospitalized for acute GE were subjected to thorough history taking, anthropometric measurements, systemic examinations including degree of dehydration (according to Vesikari Clinical Severity Score), socioeconomic status, type of nutrition, and laboratory investigations (CBC including total and differential leukocyte count, C-reactive protein (CRP), and stool examination). Leukocytosis and neutrophilia were defined according to age-related specific values for each individual case.  Imaging investigations (abdominal and pelvic ultrasound, abdominal X-ray, CT scan of abdomen and/or pelvis and barium enema) were performed when needed on case-by-case basis.
Our protocol of treatment for all cases of acute GE included oral or intravenous rehydration as clinically indicated. Metronidazole, either orally or by intravenous infusion, was used to all confirmed E. histolytica cases. Third generation cephalosporin, either orally or by intravenous infusion, was used for acute GE cases with clinical (high grade fever and toxic state) and/or laboratory (leukocytosis and positive CRP) evidence of invasive gastroenteritis or possible unrevealed coinciding bacterial infections that are associated with E. histolytica infection. , Blood cultures were also done for these cases to detect possible associated bacteremia.The patient course of illness, follow-up, and response to treatment were recorded in medical charts for each admitted case with acute GE.
Sampling and laboratory techniques
Fresh stool samples were collected in sterile containers and sent within a maximum period of 2 h to the hospital laboratory.
Examination of feces for protozoa and helminthes
Stool specimens were examined for intestinal parasites within 30 min of collection. The examination took place in the parasitology section at the Department of Pathology and Laboratory Medicine at MGH. Stool specimens were first grossly checked for the presence of complete or part of adult parasites then by light microscopy using a concentration technique according to the manufacturer's instructions (Fecal Parasite Concentrator (FPC), Evergreen Scientific, Los Angeles, CA, USA).
One spoonful of stool specimen was mixed with 9 ml of 10% formalin in a 15 ml sterile tube. The mixture was kept at room temperature for 30 min for fixation. Three drops of Triton X-100 (surfactant) were added, followed by 3 ml of ethyl acetate to dissolve fat and reduce the bulk of stool.
The mixture was transferred to a 15 ml centrifuge tube through the FPC strainer attached to the tube. This FPC strainer has a precision molded filter matrix (0.6 × 0.6 mm 2 holes) that allows helminthes eggs and larvae, protozoan cysts, and coccidian oocytes to pass but will retain the coarse particulate matter (excess fecaldebris). After completing this filtration step, the tube was capped and centrifuged at 2000 ppm for 10 min. The supernatant was decanted, and 3 drops of 10 ml of 10% formalin were added and mixed with the sediment. Part of the latter was transferred to a slide and examined for parasites under the light microscope. In addition "watery stool" was also examined microscopically without concentration looking for trophozoites of parasites. Coccidian parasites, e.g. Cryptosporidium and Cyclospora were looked for using modified acid fast stain. 
Examination of feces for viruses
Rotavirus was detected after collecting sufficient quantity of feces (1-2 g or 1-2 ml) in a clean dry container and the fecal specimen was analyzed by Omega Virotect Rota (Omega Diagnostics, Omega House, Hill foots Business Village, AlvaFK12 5DQ, Scotland, United Kingdom). It is a rapid latex slide test (qualitative test) for detection of RV in human feces with a relative sensitivity of 97.2% and relative specificity of 97.1%. 
Examination of feces for bacterial enteropathogens
Stool cultures for enteric bacteria were mainly limited to Salmonella More Details, Shigella spp and Shiga toxin producing Escherichia More Details coli as E. coli serotype 0157:H7 based on the ability of such enteropathogens to cause dysentery-like illness such as E. histolytica, the previous epidemiologic prevalence of these enteropathogens in stool cultures of our locality, and the availability of their diagnostic tests. Shigella and Salmonella were identified by standard bacteriologic methods with primary isolation on MacConkey, XLD (xylose lysine deoxycholate) agar, and Salmonella-Shigella agar to inhibit the growth of normal flora and growth amplification of Salmonella in celenite broth. , Further biochemical or serological identification was done for the detected Salmonella and Shigella species.
The diagnosis of diarrheagenic E. coli infection was made by initial isolation of the bacteria from stool cultures, and based on biochemical criteria (e.g. fermentation patterns). Entero-hemorrhagic E. coli (EHEC or O157:H7) was suggested by the failure to ferment sorbitol on MacConkey sorbitol medium.  Campylobacter species were not cultured due to lack of specific medium at our laboratory.
Analysis was done using statistical package for social science program version 19. Data were reported as mean standard deviation (SD), or number of patients (percentage). T-test (two-tailed) and Chi-square test were used to assess any significant difference between the groups. P < 0.05 were considered statistically significant.
| Results|| |
Three thousand one hundred ninety-six patients presented to MGH due to acute GE between January 2008 and December 2012.One thousand six hundred ninety-six patients were excluded from the study due to incomplete documentation in their medical charts, and one hundred five patients were also excluded because they failed to fulfill the inclusion criteria: Presence of simultaneous or combined infections. The most common combined infection associated with E. histolytica was Salmonella infection (in 43 cases) and they were also among the excluded cases in the study.
One thousand three hundred ninety-five pediatric patients hospitalized for acute GE were included in the study, and were subsequently divided into four main groups: Group I (E. histolytica group = 311 cases), group II (RV group = 427 cases), group III (bacterial group = 107 cases), group IV (unidentified group = 550 cases). The bacterial group comprised cases of gastroenteritis due to the following bacteria: Salmonella species (70 cases, 65.5%), enteropathogenic E. coli (33 cases, 30.8%) and Shigella (4 cases, 3.7%).
The most prevalent identified enteropathogen was RV (30.6%), followed by E. histolytica (22.3%) and then enteric bacteria (7.7%), however, the majority of the enteropathogens were unidentified (39.4%).The percentage of cases under 1 year of age was significantly higher in RV group than in other 3 groups (P < 0.0001) [Table 1]. However, when considering the frequency of E. histolytica among different age groups, it shows that E. histolytica was more frequent below 1 year of age (25.7%) and this frequency decreases as age increases [Figure 1]. No statistically significant difference was found between the four studied groups regarding gender, but E. histolytica, RV and unidentified enteropathogens were significantly prevalent in the low socio-economic group. Regarding residency, E. histolytica was significantly prevalent in patient coming from the north (50%) (P = 0.024) [Table 1].
|Table 1: Comparison of the demographic characteristics among the 4 studied groups|
Click here to view
Cases were admitted with acute GE due to E. histolytica because of any or combination of the following symptoms: High grade fever, vomiting, abdominal pain, bloody or mucoidy diarrhea and varying degrees of dehydration. [Table 2] shows the comparison of the various clinical manifestations and laboratory findings of E. histolytica between three different age groups (<1 year, 1-5 years and 6-15 years). The group of infants under 1 year presented with significantly higher degrees of dehydration than the 1-15 years age group (P = 0.008). The 1-15 years group had significantly higher presentation with abdominal pain, vomiting, and neutrophilia on laboratory findings than the group of infants less than 1 year (P < 0.0001). (P < 0.0001). CRP was significantly positive in all age groups (P < 0.0001). No statistically significant difference was detected among the 3 age groups regarding symptoms of fever, bloody, and mucoidy diarrhea [Table 2].
|Table 2: Clinical manifestations, laboratory fi ndings and imaging studies of hospitalized cases of E. histolytica among the three main age groups|
Click here to view
The risk factors for acute GE were also studied among the four studied groups. Significantly higher percentage of E. histolytica cases was observed among breastfed infants and children compared to RV cases (P1 < 0.0001). Bottle feeding displays a significant risk factor of acute GE among the four studied groups (P1 = 0.029, P2 = 0.047 and P3 < 0.0001). There was no significant difference regarding the nutritional status of infants and children among the four studied groups [Table 3].
[Table 4] shows the percentages of variable clinical manifestations, laboratory findings, imaging studies, and medications among the four studied groups. Symptoms such as abdominal pain with bloody and mucoidy diarrhea were significantly higher in E. histolytica group more than other 3 groups (P1 < 0.0001, P2 < 0.0001 and P3 < 0.0001, respectively). High grade fever was significantly frequent in E. histolytica and bacterial groups (P1 < 0.0001 and P2 < 0.0001), whereas vomiting was a more frequent symptom in E. histolytica and RV groups (P2 < 0.0001 and P3 < 0.0001). The severity of dehydration was higher in both E. histolytica and bacterial groups than in RV and unidentified groups (P1 < 0.0001 and P3 = 0.001). However, there was no significant difference in the mean duration of symptoms and hospital stay among the four studied groups [Table 4]. Laboratory findings and imaging studies of all hospitalized GE cases were also studied among the four main groups. Laboratory findings presented significantly higher percentages of leukocytosis with neutrophilia for age in both E. histolytica and bacterial groups than the other 2 groups (P1 < 0.0001 and P3 < 0.0001), however, the presence of bands and positive CRP were significantly higher in E. histolytica group than the other 3 groups (P1 < 0.0001, P2 < 0.01 and P3 < 0.001, respectively) [Table 4]. Imaging studies showed statistically high percentages in E. histolytica group compared with the other 3 groups, as 33.4% (104 cases/311) of E. histolytica group were exposed to imaging compared to 6% (6 cases/427) of RV group, 14% (15 cases/107) of bacterial group, and 5.6% (31 cases/550) of unidentified group (P1 < 0.0001, P2 < 0.0001, and P3 < 0.0001, respectively). These imaging studies included: Ultrasound abdomen which was done in 48.1% (50 cases/104) of E. histolytica group, abdominal X-ray was done in 21.2% (22 cases/104) of E. histolytica group and CT scan of abdomen was performed in 2.9% (3 cases/104) of E. histolytica group, but the most striking imaging studies were barium enema and combined imaging which were done in 13.5% (14 cases/104) and 14.4% (15 cases/104) of E. histolytica group, respectively, and were performed mostly in the age group of infants less than 1 year (P < 0.0001) [Table 2]. Almost all cases of E. histolytica showed favorable response to our protocol of treatment that included oral or intravenous rehydration with metronidazole, with regression of symptoms within a mean duration of 2-3 days, however, 12% (38 cases/311) of patients with E. histolytica infection received 3 rd generation cephalosporin, in addition to metronidazole [Table 4]. The frequency of E. histolytica as a cause of acute GE among children is increasing throughout years as its frequency doubled from year 2008 (14.9%) to year 2012 (28.9%) [Figure 2]. Regarding seasonal variation of the studied enteropathogens, it seems that E. histolytica infection has a specific seasonal pattern. It is prevalent all over the year with peak prevalence during summer and autumn, whereas, RV infection has the opposite seasonal pattern [Figure 3].
|Table 4: Comparison of the clinical manifestations, laboratory fi ndings, imaging studies, and medications among the 4 studied groups|
Click here to view
| Discussion|| |
In this study, admitted cases of GE at MGH, during the period between January 2008 and December 2012, were found to be 1395 cases out of 3196 total pediatric GE case presented to our hospital during the same period. Cases admitted with E. histolytica (311) constituted 22.3% of total admitted cases of GE. The diagnosis of E. histolytica infection was based on detection of E.histolytica trophozoites or cysts in several fresh stool samples sent for Fecal Parasite Concentrator, which is an efficient device to concentrate parasites and protozoa,  as the E. histolytica antigen detection test was not available at our locality. Moreover, these hospitalized E. histolytica cases had symptoms of parasitic GE.
This study showed that the prevalence of E. histolytica is 22.3% of all hospitalized pediatric GE cases, which corroborates previous studies from Asia and East Africa as the prevalence of E. histolyitca among pediatric GE cases was 20.0% in Saudi Arabia,  18.0% in Tanzania,  17.1% in Yemen  and 25.9% in Tajikistan.  In Lebanon, two previous studies were conducted by Araj et al., at American University of Beirut Medical Center, and Hamze et al., at North Lebanon. Both studies reviewed the parasitology records of the general population, regardless of correlation with clinical manifestations, and both showed that the prevalence of E. histolytica infection is 2% in the age group below 15 years, and 4.57% in adults, respectively. , In our study, the increased prevalence of E. histolytica infection among inpatient pediatric GE cases may be attributed to concerning risk factors. Moreover, there was a considerable number of inpatients under 1 year infected with E. histolytica (80/311, 25.7%), which is an unusual presentation in this age group because E. histolytica is usually transmitted via fecal oral route with contaminated food and water, so young infants are less likely to develop intestinal amebiasis very often.  This increased frequency of E. histolytica infection in this small age group, may be linked to the formula feeding, with inappropriate sterilization techniques of bottles, and the use of unimproved drinking water for formula preparation, all reflecting that hygiene plays a very important role in the spread of E. histolytica infection.
Low socio-economic status was the most significant demographic factor associated with high prevalence of E. histolytica among infants and children, and this is probably due to low level of public and individual hygienic conditions.  Regarding residency, despite majority of inpatient pediatric GE cases were from the capital Beirut, almost 50% of hospitalized GE cases coming from North Lebanon had E. histolytica infection. However, this cannot be relied on, due to the small number (18 cases) of GE cases presenting from the North. Otherwise, gender and residency had no statistically significant effect on the prevalence of E. histolytica infection [Table 1].
Taking into consideration the various clinical manifestations associated with intestinal amebiasis, infants less than 1 year of age presented with more severe degrees of dehydration. Besides we had two cases admitted to intensive care units: The first case was 14 days old infant admitted for GE and was found to have E. histolytica infection, and the second one was 28 days old infant admitted for severe dehydration and was diagnosed to have E. histolytica infection. This implies that infants under 1 year presented with moderate to severe dehydration secondary to E. histolytica infection and could be protected by exclusive breastfeeding and improved hygienic practices. On the other hand, symptoms such as fever, vomiting, mucoidy and bloody diarrhea were noticed similarly among all age groups of E. histolytica GE. The group of children above 1 year of age had significantly higher presentation with abdominal pain than the group of infants less than 1 year (P < 0.0001). This may be related to developmental maturity of this age group to express their feelings much better than younger infants who presents more with irritability and inconsolable crying as an expression of their pain. 
Regarding risk factors to acquire E. histolytica infection, breast feeding did not have an effect on decreasing the rate of E. histolytica infection in our study, while it was protective against RV infection [Table 3]. Despite this, it is known that colostrum and mature human milk have significant lethal effect on E. histolytica, which is accomplished by bile salt-stimulated lipase in human milk that kills both Gardia lamblia and E. histolytica., This may be attributed to inadequate maternal hygiene or associated improper feeding practices as unapproved herbal remedies for infantile colic. Moreover, all studied enteropathogens were significantly prevalent in bottle-fed infants [Table 3], and this may be due to inadequate or non-sterilization of bottles. This spots the light on the importance of awareness for exclusive breastfeeding and avoidance of improper feeding practices, in addition to adequate personal hygiene and proper techniques of sterilization of bottles.
When comparing the clinical manifestations among the four studies groups, significantly high percentages of symptoms such as high grade fever, abdominal pain, vomiting, bloody or mucoidy diarrhea, and moderate to severe degrees of dehydration were found in E. histolytica group compared to the other groups, and this can be attributed to the fact that we are dealing with only severe E. histolytica cases that required admission and not outpatient E. histolytica cases.Regarding the laboratory studies in our E. histolytica cases, a significant number (>50%) of cases had leukocytosis, with neutrophilic shift, positive CRP, as well as the presence of significant numbers of band cells, which were significantly higher than both RV unidentified groups, but approximately similar to that of the bacterial group, suggesting similar presentation of intestinal amebiasis to an invasive bacterial disease.
Also a significant number of cases with E. histolytica GE underwent imaging studies of the abdomen (104/311, 33.4%) due to initial presentation with clinical picture of severe abdominal pain mimicking surgical abdomen. Moreover, 14 infants (13%), of whom 13 were below 1 year of age, presented with an initial clinical picture of intussusceptions (irritability, bloody stool, and hypoacivity) necessitating barium enemas to be performed and turned to be normal, and this severe clinical picture was due to E. histolytica infection. Besides, 12.2% (38 cases/311) of E. histolytica GE cases were started, upon initial presentation, on 3 rd generation cephalosporin as their clinical manifestations and laboratory findings were mimicking invasive bacterial GE [Table 4]. The combination of these laboratory findings, together with the severity of clinical presentation, have been described usually with amebic liver abscess, the commonest from of invasive amebiasis, and not with intestinal amebiasis, ,, and rarely with severe amebic colitis in young children when the colon was found to be necrotic with several perforations leading to peritonitis. ,
However, this unusual presentation in our patients, especially in infants, was associated only with intestinal amebiasis without the disseminated diseases mentioned above, and this was proved by the improvement of patients after initiation of metronidazole treatment within a mean of 2-3 days, and a significant number of patients underwent imaging studies such as ultrasound of abdomen and pelvis, and CT scan of abdomen, and none of these imaging studies revealed any abscess, perforation or severe colitis, this indicates the aggressive nature of E. histolytica infection in our patients, and that an early invasive disease could occur, unless if the E. histolytica infection was diagnosed early and appropriately treated.  This invasive nature was more common than expected or previously reported in the literature, and even more severe than our inpatients with GE due to other enteropathogens.
These findings were similar to a study conducted in Saudia Arabia, raising the issue that a more virulent strain of E. histolytica is responsible for such serious manifestations in the Middle East, and need to be investigated as Petri suggested that genetically distinct strains of E. histolytica might exist and are more virulent than others. , Besides this aggressive presentation of E. histolytica in our cases may also need further evaluation to reveal a possible underlying immunologic mechanism that might be responsible for such severe E. histolytica cases at our country and in Saudi Arabia.  Regarding the mean duration of hospitalization, cases with E. histolytica GE had mean duration of hospital stay of 3 days, similar to other groups, with average cost of 1800$ for each case.
Finally, E. histolytica infection is increasing throughout years as its prevalence doubled from year 2008 (14.9%) to year 2012 (28.9%), and this reflects deterioration in both public and individual hygienic standards, besides unimproved drinking water plays a contributing role in such increase in E. histolytica infection. Besides, E. histolytica GE is prevalent all over the year, but it seems to have its highest prevalence during summer and autumn seasons, opposite to Rotavirus infection, which makes E. histolytica in our locality, on the top of list of differential diagnosis for acute GE among children in these two seasons.
Limitation of the study
This study was a retrospective one, some of the data were not fully available, and however, we relied on every single documentation in the patients' medical charts. This study included one tertiary care referral center in Beirut, but it would have been better if it could include more medical centers in various regions of Lebanon, to be a multicenter study and to provide more informative data regarding the prevalence and nature of E. histolytica infection. However, the number of pediatric patients admitted to our hospital represents a sufficient sample to be studied in our region. Another limitation is unavailability of E. histolytica antigen detection test to confirm and increase the yield for diagnosis of E. histolytica infection. Besides, there was no specific medium for Campylobacter spp. in the microbiology section at the Department of Laboratory Medicine at our hospital. Despite this, all hospitalized E. histolytica cases had typical manifestations of amebic gastroenteritis, and moreover, they responded well to the treatment with metronidazole.
This study raises the issue of a public health problem which reflects deterioration in hygienic measures in our country, with predominance in low socio-economic status, and for sure the presence of contaminated water supplies.
Health care providers should advice for better hygiene, especially in the low socioeconomic group, with education for better sterilization techniques of water and bottles especially in infants under 1 year of age.
Improved water and food supplies by the government should be applied, including protection and mandatory inspection measures to reduce the rate of infection with E. histolytica.
| Conclusions|| |
The prevalence of E. histolytica infection is increasing throughout years. It is accompanied with severe manifestations, and unusual presentation in infants and children.
Severe clinical manifestations and laboratory findings suggestive of a severe invasive disease (leukocytosis, neutrophilia, positive CRP, presence of bands) were found in almost more than 50% of patients with E. histolytica infection in our hospital.
This denotes that E. histolytica infection is an emerging serious disease, not only a simple gastroenteritis, especially in low socio-economic and poor hygienic conditions. And it is an important cause of hospitalization and financial burden in our country.
So we must be ready for this serious infection with more effective and powerful preventive measures.
| References|| |
|1.||Haque R, Mondal D, Kirkpatrick BD, Akther S, Farr BM, Sack RB, et al. Epidemiologic and clinical characteristics of acute diarrhea with emphasis on Entamoeba histolytica infections in preschool children in an urban slum of Dhaka, Bangladesh. Am J Trop Med Hyg 2003;69:398-405. |
|2.||Hegazi M, Patel E, El-Deek B. Prevalence and characters of Entamoeba histolytica infection in Saudi infants and children admitted with diarrhea at 2 main hospitals at south Jeddah: A re-emerging serious infection with unusual presentation. Braz J Infect Dis 2013;17:32-40. |
|3.||John CC, Salata RA. Amebiasis. In: Kliegman RM, Stanton B, St. Geme J, Schor N, Behrman RE, editors. Nelson textbook of pediatrics. Philadelphia: Saunders; 2010. p. 1123-5. |
|4.||Pham Duc P, Nguyen-Viet H, Hattendorf J, Odermatt P. Risk factors for Entamoeba histolytica infection in an agricultural community in Hanam province, Vietnam. Parasit Vectors 2011;4:102. |
|5.||Noor Azian MY, Lokman HS, Maslawaty MN. Use of molecular tools to distinguish Entamoeba histolytica and Entamoeba dispar infection among the aborigines in Cameron Highlands. Trop Biomed 2006;23:31-6. |
|6.||Qvarnstrom Y, James C, Xayavong M, Holloway BP, Visvesvara GS, Sriram R, et al. Comparison of real-time PCR protocols for differential laboratory diagnosis of amebiasis. J Clin Microbiol 2005;43:5491-7. |
|7.||Pestehchian N, Nazary M, Haghighi A, Salehi M, Yosefi H. Frequency of Entamoeba histolytica and Entamoeba dispar prevalence among patients with gastrointestinal complaints in Chelgerd city, southwest of Iran. J Res Med Sci 2011;16:1436-40. |
|8.||Tan ZN, Wong WK, Nik Zairi Z, Abdullah B, Rahmah N, Zeehaida M, et al. Identification of Entamoeba histolytica trophozoites in fresh stool sample: Comparison of three staining techniques and study on the viability period of the trophozoites. Trop Biomed 2010;27:79-88. |
|9.||Voigt H, Olivo JC, Sansonetti P, Guillen N. Myosin IB from Entamoeba histolytica is involved in phagocytosis of human erythrocytes. J Cell Sci 1999;112:1191-201. |
|10.||Wilson IW, Weedall GD, Hall N. Host-Parasite interactions in Entamoeba histolytica and Entamoeba dispar: What have we learned from their genomes? Parasite Immunol 2012;34:90-9. |
|11.||Petri WA, Haque R, Mann BJ. The bittersweet interface of parasite and host: Lectincarbohydrate interactions during huinvasion by the parasite Entamoeba histolytica. Annu Rev Microbiol 2002;56:39-64. |
|12.||Lidell ME, Moncada DM, Chadee K, Hansson GC. Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proc Natl Acad Sci USA 2006;103:9298-303. |
|13.||Lejeune M, Rybicka JM, Chadee K. Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica. Future Microbiol 2009;4:105-18. |
|14.||Al-Harthi S, Jamjoom M. Diagnosis and differentiation of entamoeba infection in Makhah Al Mukarramah using microscopy and stool antigen detection kits. World J Med Sci 2007;2:15-20. |
|15.||Norhayati M, Fatmah MS, Yusof S, Edariah AB. Intestinal parasitic infections in man: A review. Med J Malaysia 2003;58:296-305. |
|16.||Ilikkan DY, Ilikkan B, Vural M. Amebiasis in infancy in the middle-high socioeconomic class in Istanbul, Turkey. Pediatr Infect Dis J 2005;24:929-30. |
|17.||Araj GF, Musharrafieh UM, Haydar A, Ghawi A, Itani R, Saliba R. Trends and prevalence of intestinal parasites at a tertiary care center in Lebanon over a decade. J Med Liban 2011;59:143-8. |
|18.||Nicholson JF, Pesce MA. Reference ranges for laboratory tests and procedures. In: Kliegman RM, Stanton B, St. Geme J, Schor N, Behrman RE, editors. Nelson Textbook of Pediatrics. Philadelphia: Saunders; 2010. p. 2396-42. |
|19.||Haque R, Faruque AS, Hahn P, Lyerly DM, Petri WA. Entamoeba histolytica and Entamoeba dispar Infection in Children in Bangladesh. J Infect Dis 1997;175:734-6. |
|20.||Powell KR. Fever without a focus. In: Kliegman RM, Stanton B, St. Geme J, Schor N, Behrman RE, editors. Nelson Textbook of Pediatrics. Philadelphia: Saunders; 2010. p. 841-6. |
|21.||Xiao L, Cama V. Cryptosporidia. In: Murray PR, Baron JH, Jorgensen ML, Landry ML, Pfaller MA, editors. Manual of Clinical Microbiology. 9 th ed. Washington, DC: ASM Press; 2007. p. 2122-32. |
|22.||Cheun HI, Cho SH, Lee JH, Lim YY, Jeon JH, Yu JR, et al. Infection status of hospitalized diarrheal patients with gastrointestinal protozoa, bacteria, and viruses in the Republic of Korea. Korean J Parasitol 2010;48:113-20. |
|23.||Oberhelman RA, Flores-Abuxapqui J, Suarez-Hoil G, Puc-Franco M, Heredia-Navarrete M, Vivas-Rosel M, et al. Asymptomatic salmonellosis among children in day-care centers in Mérida, Yucatan, Mexico. Pediatr Infect Dis J 2001;20:792-7. |
|24.||Zaki AM, DuPont HL, el Alamy MA, Arafat RR, Amin K, Awad MM, et al. The detection of enteropathogens in acute diarrhea in a family cohort population in rural Egypt. Am J Trop Med Hyg 1986;35:1013-22. |
|25.||Theresa J, Ochoa TJ, Cleary TG. Escherichia coli. In: Kliegman RM, Stanton B, St. Geme J, Schor N, Behrman RE, editors. Nelson Textbook of Pediatrics. Philadelphia: Saunders; 2010. p. 921-4. |
|26.||Speich B, Marti H, Ame SM, Ali SM, Bogoch II, Utzinger J, et al. Prevalence of intestinal protozoa infection among school-aged children on Pemba Island, Tanzania, and effect of single-dose albendazole, nitazoxanide and albendazole nitazoxanide. Parasit Vectors 2013;6:3. |
|27.||Alyousefi N, Mahdy M, Mahmud R, Lim Y. Factors associated with high prevalence of intestinal protozoan infections among patients in Sana'a city, Yemen. PLoS One 2011;6:e22044. |
|28.||Matthys B, Bobieva M, Karimova G, Mengliboeva Z, Jean-Richard V, Hoimnazarova M, et al. Prevalence and risk factors oh helminths and intestinal protozoa infections among children from primary schools in western Tajikisan. Parasit Vectors 2011;4:195. |
|29.||Hamze M, Dabbousi F, Al-Ali K, Ourabi L. Prevalence of intestinal parasites in north Lebanon: 1997-2001. East Mediterr Health J 2004;10:343-8. |
|30.||Akisu C, Aksoy U, Cetin H, Ustun S, Akisu M. Effect of human milk and colostrum on Entamoeba histolytica. World J Gastroenterol 2004;10:741-2. |
|31.||Heird WC. Page: The feeding of infants and children. In: Kliegman RM, Stanton B, St. Geme J, Schor N, Behrman RE, editors. Nelson Textbook of Pediatrics. Philadelphia: Saunders; 2010. p. 157-67. |
|32.||Cosme A, Ojeda E, Zamarreño I, Bujanda L, Garmendia G, Echeverría MJ, et al. Pyogenic versus amoebic liver abscesses: A comparative clinical study in a series of 58 patients. Rev Esp Enferm Dig 2010;102:90-9. |
|33.||Watanabe K, Gatanaga H, Escueta-de Cadiz A, Tanuma J, Nozaki T, Oka S. Amebiasis in HIV-1-infected Japanese men: Clinical features and response to therapy. PLoS Negl Trop Dis 2011;5:e1318. |
|34.||Roy Choudhury S, Sen AK. Necrotizing amebic colitis in a child. Pediatr Surg Int 2002;18:498-500. |
|35.||Yamada H, Matsuda K, Akahane T, Shimada R, Horiuchi A, Shibuya H, et al. A case of fulminant amebic colitis with multiple large intestinal perforations. Int Surg 2010;95:356-9. |
|36.||Petri WA. Entamoeba histolytica: Clinical update and vaccine prospects. Curr Infect Dis Rep 2002;4:124-9. |
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||Acute Infectious Gastroenteritis: The Causative Agents, Omics-Based Detection of Antigens and Novel Biomarkers
| ||Haziqah Hasan, Nor Ashika Nasirudeen, Muhammad Alif Farhan Ruzlan, Muhammad Aiman Mohd Jamil, Noor Akmal Shareela Ismail, Asrul Abdul Wahab, Adli Ali |
| ||Children. 2021; 8(12): 1112 |
|[Pubmed] | [DOI]|
||Prevalence, risk factors, and clinical characteristics of rotavirus and adenovirus among Lebanese hospitalized children with acute gastroenteritis
| ||Rasha Zaraket,Ali Salami,Marwan Bahmad,Ali El Roz,Batoul Khalaf,Ghassan Ghssein,Hisham F. Bahmad |
| ||Heliyon. 2020; 6(6): e04248 |
|[Pubmed] | [DOI]|
||Prevalence, risk factors and seasonal variations of different Enteropathogens in Lebanese hospitalized children with acute gastroenteritis
| ||Ali Salami,Hadi Fakih,Mohamed Chakkour,Lamis Salloum,Hisham F. Bahmad,Ghassan Ghssein |
| ||BMC Pediatrics. 2019; 19(1) |
|[Pubmed] | [DOI]|
||Surveillance Study of Acute Gastroenteritis Etiologies in Hospitalized Children in South Lebanon (SAGE study)
| ||Ghassan Ghssein,Ali Salami,Lamis Salloum,Pia Chedid,Wissam H Joumaa,Hadi Fakih |
| ||Pediatric Gastroenterology, Hepatology & Nutrition. 2018; 21(3): 176 |
|[Pubmed] | [DOI]|
||Entamoeba histolytica: an Overview
| ||Nadia A. El-Dib |
| ||Current Tropical Medicine Reports. 2017; |
|[Pubmed] | [DOI]|
||Update on the epidemiology of rotavirus in the Middle East and North Africa
| ||Hassan Zaraket,Rana Charide,Khalil Kreidieh,Ghassan Dbaibo,Nada M. Melhem |
| ||Vaccine. 2017; 35(45): 6047 |
|[Pubmed] | [DOI]|